Erasca (ERAS) Operating Expenses (2020 - 2026)
Erasca (ERAS) reported Operating Expenses of $187.9 million for Q1 2026, up 427.4% on a YoY basis from $35.6 million in Q1 2025, and up 476.34% quarter-over-quarter from $32.6 million in Q4 2025.
Erasca (ERAS) Operating Expenses (2020 - 2026) Analysis & Trends
Erasca has reported Operating Expenses for 7 years, with the latest figure at $187.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 427.4% year-over-year to $187.9 million; the trailing twelve-month figure through Mar 2026 stood at $293.2 million (up 66.24% YoY), and the FY2025 full-year result was $140.9 million, down 21.54% from the prior year.
- Operating Expenses for Q1 2026 stood at $187.9 million, up from $32.6 million in the prior quarter.
- The five-year high for Operating Expenses was $187.9 million in Q1 2026, with the low at $32.6 million in Q4 2025.
- Historically, Operating Expenses has averaged $52.8 million across 5 years, with a median of $36.5 million in 2022.
- Annual changes were most pronounced in 2023 — Operating Expenses tumbled 75.47% — and 2026, when it surged 427.4%.
- Erasca's Operating Expenses stood at $138.1 million in 2022, then plunged by 75.47% to $33.9 million in 2023, then climbed by 5.43% to $35.7 million in 2024, then declined by 8.7% to $32.6 million in 2025, then soared by 476.34% to $187.9 million in 2026.
- The last three Operating Expenses figures came in at $187.9 million (Q1 2026), $32.6 million (Q4 2025), and $34.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 187.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187.91 Mn |
| Dec 31, 2025 | 32.60 Mn |
| Sep 30, 2025 | 34.55 Mn |
| Jun 30, 2025 | 38.13 Mn |
| Mar 31, 2025 | 35.63 Mn |
| Dec 31, 2024 | 35.71 Mn |
| Sep 30, 2024 | 37.24 Mn |
| Jun 30, 2024 | 67.78 Mn |
| Mar 31, 2024 | 38.85 Mn |
| Dec 31, 2023 | 33.87 Mn |
| Sep 30, 2023 | 34.66 Mn |
| Jun 30, 2023 | 35.97 Mn |
| Mar 31, 2023 | 37.03 Mn |
| Dec 31, 2022 | 138.08 Mn |
| Sep 30, 2022 | 36.96 Mn |
| Jun 30, 2022 | 35.91 Mn |
| Mar 31, 2022 | 36.51 Mn |
| Dec 31, 2021 | 31.05 Mn |
| Sep 30, 2021 | 46.04 Mn |
| Jun 30, 2021 | 28.18 Mn |